MPC-6827

· Myrexis Inc.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for MPC-6827, covering 2008-02-13 to 2011-10-14. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2 Study MPC-6827 for Recurrent Glioblastoma Multiforme [Phase 2]